Lynne A. Bui's most recent trade in Tharimmune Inc was a trade of 2,353 Options (right to buy) done . Disclosure was reported to the exchange on Aug. 9, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tharimmune Inc | Lynne A. Bui | Director | 09 Aug 2024 | 2,353 | 27,353 | - | - | Options (right to buy) | ||
| Hillstream BioPharma Inc | Lynne A. Bui | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 50,000 | 50,000 | - | - | Options (right to buy) |